Environmental and Molecular Mutagenesis · 2003 · 19 citations · 22 references
PharmacyGeneticsToxicologyEnvironmental ToxicologyGenetic ToxicologyMolecular ToxicologyCellular ToxicologyEnvironmental GenotoxicantsGenotoxicity MechanismsMolecular Mechanisms Of ToxicityMutagenicity AssessmentCarcinogen-metabolizing EnzymesDna Damage InductionEpoxide Hydrolase ActivityMicrosomal Enzyme ActivityMutagenic MechanismsSensitivityXenobiotic Detoxification
The specific role that polymorphisms in xenobiotic metabolizing enzymes play in modulating sensitivity to 1,3-butadiene (BD) genotoxicity has been relatively unexplored. The enzyme microsomal epoxide hydrolase (mEH) is important in detoxifying the mutagenic epoxides of BD (butadiene monoepoxide [BDO], butadiene diepoxide [BDO(2)]). Polymorphisms in the human mEH gene appear to affect the function of the enzyme. We exposed mice with normal mEH activity (WT) and knockout mice without mEH activity (KO) to 20 ppm BD (inhalation) or 30 mg/kg BDO(2) (intraperitoneal [IP] injection). We then compared Hprt mutant frequencies (MFs) among these groups. KO mice exposed to BD exhibited a significant (P < 0.05) 12.4-fold increase in MF over controls and a significant 5.4-fold increase in MF over exposed WT mice. Additionally, KO mice exposed to BDO(2) exhibited a significant 4.5-fold increase in MF over controls and a significant 1.7-fold increase in MF over exposed WT mice. We also compared genomic damage in WT and KO mice (comet tail moment) following IP exposure to 3 mg/kg and 30 mg/kg BDO(2). KO mice exposed to 3 mg/kg exhibited significantly more DNA damage than controls (7.5-12.1-fold increase) and exposed WT mice (3 mg/kg; 4.8-fold increase). KO mice exposed to 30 mg/kg BDO(2) exhibited significantly more DNA damage than all other groups (2.3-27.9-fold increase). Correlation analysis indicated that a significant, positive relationship (r(2) = 0.92) exists between comet-measured damage and Hprt MFs. The lack of mEH activity increases the genetic sensitivity of mice exposed to BD and BDO(2). This model should facilitate a mechanistic understanding of the observed variation in human genetic sensitivity following exposure to BD.
22
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
A. J. Zuckerman · Journal of Clinical Pathology · 1995 · 8.8K citations · Full text
Medicine, Oncology, Toxicology +14
IARC monographs on the evaluation of carcinogenic risks to humans
Analytica Chimica Acta · 1996 · 1.1K citations
Medicine, Oncology, Toxicology +14
J Huff, R. L. Melnick, H. A. Solleveld et al. · Science · 1985 · 267 citations
Pharmacy, Oncology, Toxicology +16